Loading...
XNYS
DOCS
Market cap8.62bUSD
Dec 05, Last price  
45.93USD
1D
-10.49%
1Q
-33.76%
IPO
-17.95%
Name

Doximity Inc

Chart & Performance

D1W1MN
XNYS:DOCS chart
P/E
38.64
P/S
15.12
EPS
1.19
Div Yield, %
Shrs. gr., 5y
2.06%
Rev. gr., 5y
37.42%
Revenues
570m
+19.98%
85,695,000116,388,000206,897,000343,548,000419,052,000475,422,000570,399,000
Net income
223m
+51.23%
7,833,00029,737,00050,210,000154,783,000112,818,000147,582,000223,185,000
CFO
273m
+48.44%
15,306,00026,199,00082,973,000126,575,000179,602,000184,096,000273,265,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
IPO date
Jun 24, 2021
Employees
900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT